Lurasidone

Lurasidone, which is expected to reach the market in 2011, would also compete with generic versions of these products from the U.S. and European giants when they start going off patent from 2011 in the U.S.

Dainippon Forges Into U.S. Market 2009

Lurasidone, which is expected to hit the market in 2011 should help recover this, but that's far from guaranteed.

Is Sepracor the Right Prescription for Dainippon Sumitomo? 2009

But while Lurasidone, Dainippon's new schizophrenia drug, could be one remedy for expiring or expired patents on some of its main products, the company would compete in the U.S. with popular products including Eli Lilly

Dainippon Forges Into U.S. Market 2009

Analysts had been speculating that Dainippon would initially sell Lurasidone in the U.S. for schizophrenia treatment on its own or with a local partner, but the acquisition could prove helpful when the drug's target market is eventually expanded to depression treatment.

Dainippon Forges Into U.S. Market 2009

Dainippon President Masayo Tada said launching Lurasidone in the U.S. is necessary to maximize profits from the drug, even though the company doesn't yet have all the results of studies.

Dainippon Forges Into U.S. Market 2009

The deal for Sepracor, which sells drugs to treat nervous-system problems, certainly would open a sales channel for Dainippon's upcoming schizophrenia drug, Lurasidone, in the U.S.

Is Sepracor the Right Prescription for Dainippon Sumitomo? 2009

Lurasidone has high affinities for dopamine D (2), serotonin

BioSpace.com Featured News and Stories 2010

THURSDAY, Oct. 28 (HealthDay News) -- Lurasidone HCI (Latuda) tablets have been approved by the U.S.

BusinessWeek.com -- Top News 2010

Dainippon plans to file for U.S. marketing approval next year of its experimental schizophrenia drug Lurasidone.

unknown title 2009

Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study

WN.com - Articles related to Hypertension on the rise 2010